TreeWAS – Variant ID: rs1750491

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.969	0.031
I08 Multiple valve diseases	0.000	0.972	0.028
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.973	0.027
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.979	0.021
I05-I09 Chronic rheumatic heart diseases	0.000	0.980	0.020
I08.0 Disorders of both mitral and aortic valves	0.000	0.980	0.020
I08.9 Multiple valve disease, unspecified	0.000	0.980	0.020
I09 Other rheumatic heart diseases	0.000	0.982	0.018
I06 Rheumatic aortic valve diseases	0.000	0.983	0.017
I09.9 Rheumatic heart disease, unspecified	0.000	0.984	0.016
I05 Rheumatic mitral valve diseases	0.000	0.984	0.016
I07 Rheumatic tricuspid valve diseases	0.000	0.985	0.015
I08.8 Other multiple valve diseases	0.000	0.985	0.015
I06.1 Rheumatic aortic insufficiency	0.000	0.987	0.013
I06.2 Rheumatic aortic stenosis with insufficiency	0.000	0.987	0.013
I06.9 Rheumatic aortic valve disease, unspecified	0.000	0.987	0.013
I09.8 Other specified rheumatic heart diseases	0.000	0.987	0.013
I09.2 Chronic rheumatic pericarditis	0.000	0.987	0.013
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.000	0.987	0.013
I09.0 Rheumatic myocarditis	0.000	0.987	0.013
I06.0 Rheumatic aortic stenosis	0.000	0.987	0.013
F52.2 Failure of genital response	0.013	0.987	0.000
I05.2 Mitral stenosis with insufficiency	0.000	0.987	0.013
I06.8 Other rheumatic aortic valve diseases	0.000	0.988	0.012
I05.0 Mitral stenosis	0.000	0.988	0.012
I05.1 Rheumatic mitral insufficiency	0.000	0.988	0.011
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.000	0.989	0.011
I05.8 Other mitral valve diseases	0.000	0.989	0.011
H18.4 Corneal degeneration	0.011	0.989	0.000
I07.1 Tricuspid insufficiency	0.000	0.989	0.011
I07.9 Tricuspid valve disease, unspecified	0.000	0.989	0.011
I07.8 Other tricuspid valve diseases	0.000	0.989	0.011
I07.2 Tricuspid stenosis with insufficiency	0.000	0.989	0.011
I07.0 Tricuspid stenosis	0.000	0.989	0.011
N95.2 Postmenopausal atrophic vaginitis	0.000	0.991	0.009
S86.8 Injury of other muscles and tendons at lower leg level	0.000	0.991	0.009
I05.9 Mitral valve disease, unspecified	0.000	0.991	0.009
O36.9 Maternal care for foetal problem, unspecified	0.009	0.991	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.008	0.992	0.000
D22.4 Melanocytic naevi of scalp and neck	0.000	0.993	0.007
O36 Maternal care for other known or suspected foetal problems	0.007	0.993	0.000
O36.6 Maternal care for excessive foetal growth	0.007	0.993	0.000
H18 Other disorders of cornea	0.007	0.993	0.000
O36.4 Maternal care for intra-uterine death	0.006	0.993	0.000
C17 Malignant neoplasm of small intestine	0.006	0.994	0.000
C17.1 Jejunum	0.006	0.994	0.000
O36.0 Maternal care for rhesus isoimmunisation	0.006	0.994	0.000
F52.0 Lack or loss of sexual desire	0.006	0.994	0.000
H18.9 Disorder of cornea, unspecified	0.006	0.994	0.000
C17.9 Small intestine, unspecified	0.006	0.994	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.006	0.994	0.000
O36.8 Maternal care for other specified foetal problems	0.006	0.994	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.006	0.994	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.006	0.994	0.000
F52.7 Excessive sexual drive	0.006	0.994	0.000
F52.6 Nonorganic dyspareunia	0.006	0.994	0.000
F52.5 Nonorganic vaginismus	0.006	0.994	0.000
F52.4 Premature ejaculation	0.006	0.994	0.000
F52.3 Orgasmic dysfunction	0.006	0.994	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.006	0.994	0.000
C20 Malignant neoplasm of rectum	0.006	0.994	0.000
C16.9 Stomach, unspecified	0.006	0.994	0.000
O36.1 Maternal care for other isoimmunisation	0.005	0.994	0.000
O36.2 Maternal care for hydrops foetalis	0.005	0.995	0.000
H18.6 Keratoconus	0.005	0.995	0.000
H18.2 Other corneal oedema	0.005	0.995	0.000
C16 Malignant neoplasm of stomach	0.005	0.995	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.005	0.995	0.000
C17.0 Duodenum	0.005	0.995	0.000
C17.2 Ileum	0.005	0.995	0.000
H18.7 Other corneal deformities	0.005	0.995	0.000
H18.8 Other specified disorders of cornea	0.005	0.995	0.000
H18.1 Bullous keratopathy	0.005	0.995	0.000
H18.3 Changes in corneal membranes	0.005	0.995	0.000
H18.5 Hereditary corneal dystrophies	0.005	0.995	0.000
C15-C26 Malignant neoplasms of digestive organs	0.005	0.995	0.000
C17.8 Overlapping lesion of small intestine	0.005	0.995	0.000
C17.3 Meckel's diverticulum	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.000	0.995	0.005
C16.6 Greater curvature of stomach, unspecified	0.005	0.995	0.000
H18.0 Corneal pigmentations and deposits	0.004	0.995	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.005	0.995	0.000
B07 Viral warts	0.000	0.995	0.005
L73.2 Hidradenitis suppurativa	0.000	0.995	0.004
C24.0 Extrahepatic bile duct	0.004	0.996	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
C26 Malignant neoplasm of other and ill-defined digestive organs	0.004	0.996	0.000
C16.2 Body of stomach	0.004	0.996	0.000
C16.5 Lesser curvature of stomach, unspecified	0.004	0.996	0.000
C16.4 Pylorus	0.004	0.996	0.000
C16.1 Fundus of stomach	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
O36.3 Maternal care for signs of foetal hypoxia	0.004	0.996	0.000
L73 Other follicular disorders	0.000	0.996	0.004
C25.0 Head of pancreas	0.004	0.996	0.000
C26.9 Ill-defined sites within the digestive system	0.004	0.996	0.000
L73.9 Follicular disorder, unspecified	0.000	0.996	0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.996	0.004
C16.3 Pyloric antrum	0.004	0.996	0.000
L73.8 Other specified follicular disorders	0.000	0.996	0.004
C16.8 Overlapping lesion of stomach	0.004	0.996	0.000
C21 Malignant neoplasm of anus and anal canal	0.004	0.996	0.000
C24.1 Ampulla of Vater	0.004	0.996	0.000
U89.8 Agent resistant to other single specified antibiotic	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T39.0 Salicylates	0.000	0.996	0.004
C25 Malignant neoplasm of pancreas	0.004	0.996	0.000
K59.3 Megacolon, not elsewhere classified	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.996	0.004
S86 Injury of muscle and tendon at lower leg level	0.000	0.996	0.004
C24.8 Overlapping lesion of biliary tract	0.003	0.996	0.000
L60.8 Other nail disorders	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
C21.0 Anus, unspecified	0.003	0.997	0.000
C26.8 Overlapping lesion of digestive system	0.003	0.997	0.000
C26.1 Spleen	0.003	0.997	0.000
J06.9 Acute upper respiratory infection, unspecified	0.000	0.997	0.003
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
L73.0 Acne keloid	0.000	0.997	0.003
L73.1 Pseudofolliculitis barbae	0.000	0.997	0.003
C26.0 Intestinal tract, part unspecified	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
C21.1 Anal canal	0.003	0.997	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.997	0.003
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.003	0.997	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.003	0.997	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
C21.2 Cloacogenic zone	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.003	0.997	0.000
C23 Malignant neoplasm of gallbladder	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
H52.2 Astigmatism	0.000	0.997	0.003
S86.2 Injury of muscle(s) and tendon(s) of anterior muscle group at lower leg level	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
C24.9 Biliary tract, unspecified	0.003	0.997	0.000
C25.1 Body of pancreas	0.003	0.997	0.000
C78.7 Secondary malignant neoplasm of liver	0.003	0.997	0.000
S86.3 Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
C22.1 Intrahepatic bile duct carcinoma	0.003	0.997	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.003	0.997	0.000
C25.7 Other parts of pancreas	0.003	0.997	0.000
C25.4 Endocrine pancreas	0.003	0.997	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.997	0.003
O36.5 Maternal care for poor foetal growth	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
C21.8 Overlapping lesion of rectum, anus and anal canal	0.003	0.997	0.000
S86.0 Injury of Achilles tendon	0.000	0.997	0.003
S86.7 Injury of multiple muscles and tendons at lower leg level	0.000	0.997	0.003
M94.8 Other specified disorders of cartilage	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.003	0.997	0.000
C25.9 Pancreas, unspecified	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
F55 Abuse of non-dependence-producing substances	0.003	0.997	0.000
C25.8 Overlapping lesion of pancreas	0.002	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
C16.0 Cardia	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.000	0.997	0.003
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.003	0.997	0.000
S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level	0.000	0.997	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
C22.7 Other specified carcinomas of liver	0.002	0.997	0.000
C22.4 Other sarcomas of liver	0.002	0.997	0.000
C22.3 Angiosarcoma of liver	0.002	0.997	0.000
C22.2 Hepatoblastoma	0.002	0.997	0.000
C48.2 Peritoneum, unspecified	0.003	0.997	0.000
S86.9 Injury of unspecified muscle and tendon at lower leg level	0.000	0.997	0.002
F50 Eating disorders	0.002	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.000	0.997	0.003
N48.6 Balanitis xerotica obliterans	0.003	0.997	0.000
F51 Nonorganic sleep disorders	0.002	0.997	0.000
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.002
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.997	0.002
T40.2 Other opioids	0.000	0.997	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
U89 Agent resistant to other and unspecified antibiotics	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
O46.9 Antepartum haemorrhage, unspecified	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
C22.9 Liver, unspecified	0.002	0.998	0.000
C25.3 Pancreatic duct	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
F50.0 Anorexia nervosa	0.002	0.998	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.000	0.998	0.002
C25.2 Tail of pancreas	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
F53.9 Puerperal mental disorder, unspecified	0.002	0.998	0.000
F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
S86.00 Unspecified injury of Achilles tendon	0.000	0.998	0.002
H15.1 Episcleritis	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.002
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.002
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.002
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.002
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
M94.9 Disorder of cartilage, unspecified	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
E61.1 Iron deficiency	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
M94 Other disorders of cartilage	0.000	0.998	0.002
H15 Disorders of sclera	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
H74 Other disorders of middle ear and mastoid	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
U89.9 Agent resistant to unspecified antibiotic	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.002	0.998	0.000
K82.4 Cholesterolosis of gallbladder	0.002	0.998	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.998	0.002
F50.8 Other eating disorders	0.002	0.998	0.000
F50.5 Vomiting associated with other psychological disturbances	0.002	0.998	0.000
F50.4 Overeating associated with other psychological disturbances	0.002	0.998	0.000
F50.3 Atypical bulimia nervosa	0.002	0.998	0.000
F50.1 Atypical anorexia nervosa	0.002	0.998	0.000
F51.3 Sleepwalking [somnambulism]	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.000	0.998	0.002
F51.9 Nonorganic sleep disorder, unspecified	0.002	0.998	0.000
F51.8 Other nonorganic sleep disorders	0.002	0.998	0.000
F51.2 Nonorganic disorder of the sleep-wake schedule	0.002	0.998	0.000
F51.1 Nonorganic hypersomnia	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
F51.0 Nonorganic insomnia	0.002	0.998	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
L60 Nail disorders	0.000	0.998	0.002
L66.9 Cicatricial alopecia, unspecified	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
F51.4 Sleep terrors [night terrors]	0.002	0.998	0.000
H15.0 Scleritis	0.002	0.998	0.000
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
F51.5 Nightmares	0.002	0.998	0.000
M77.4 Metatarsalgia	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.002	0.998	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.998	0.002
L08.8 Other specified local infections of skin and subcutaneous tissue	0.000	0.998	0.002
L60.2 Onychogryphosis	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
L66 Cicatricial alopecia [scarring hair loss]	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.998	0.002
M65.86 Other synovitis and tenosynovitis (Lower leg)	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
H74.0 Tympanosclerosis	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
F50.9 Eating disorder, unspecified	0.002	0.998	0.000
L66.1 Lichen planopilaris	0.000	0.998	0.002
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.000	0.998	0.002
M94.98 Disorder of cartilage, unspecified (Other)	0.000	0.998	0.002
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.000	0.998	0.002
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M94.94 Disorder of cartilage, unspecified (Hand)	0.000	0.998	0.002
M94.93 Disorder of cartilage, unspecified (Forearm)	0.000	0.998	0.002
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.000	0.998	0.002
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.000	0.998	0.002
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
F50.2 Bulimia nervosa	0.002	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.002	0.998	0.000
M94.3 Chondrolysis	0.000	0.998	0.002
M94.1 Relapsing polychondritis	0.000	0.998	0.002
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.998	0.002
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.002	0.998	0.000
F31.9 Bipolar affective disorder, unspecified	0.002	0.998	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.998	0.002
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.998	0.002
L60.1 Onycholysis	0.000	0.998	0.002
M94.2 Chondromalacia	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.001
L60-L75 Disorders of skin appendages	0.000	0.998	0.002
S72.00 Fracture of neck of femur (closed)	0.000	0.998	0.002
H15.8 Other disorders of sclera	0.002	0.998	0.000
I49.1 Atrial premature depolarisation	0.000	0.998	0.002
L60.5 Yellow nail syndrome	0.000	0.998	0.002
L60.4 Beau's lines	0.000	0.998	0.002
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.000	0.998	0.001
C48.0 Retroperitoneum	0.002	0.998	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.002	0.998	0.000
M77.49 Metatarsalgia-Site unspec	0.002	0.998	0.000
M77.48 Metatarsalgia-Other	0.002	0.998	0.000
M77.46 Metatarsalgia-Lower Leg	0.002	0.998	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.002	0.998	0.000
M77.44 Metatarsalgia-Hand	0.002	0.998	0.000
M77.43 Metatarsalgia-Forearm	0.002	0.998	0.000
M77.42 Metatarsalgia-Upper arm	0.002	0.998	0.000
M77.41 Metatarsalgia-Shldr region	0.002	0.998	0.000
M77.40 Metatarsalgia-Mult sites	0.002	0.998	0.000
C78.2 Secondary malignant neoplasm of pleura	0.002	0.998	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.998	0.002
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.998	0.000
H21.0 Hyphaema	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.001
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.002	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.002	0.998	0.000
L66.4 Folliculitis ulerythematosa reticulata	0.000	0.998	0.002
L66.3 Perifolliculitis capitis abscedens	0.000	0.998	0.002
L66.2 Folliculitis decalvans	0.000	0.998	0.002
L66.0 Pseudopelade	0.000	0.998	0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
H74.1 Adhesive middle ear disease	0.000	0.998	0.002
L60.9 Nail disorder, unspecified	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.001
J06 Acute upper respiratory infections of multiple and unspecified sites	0.000	0.998	0.002
B00.5 Herpesviral ocular disease	0.000	0.998	0.002
L60.3 Nail dystrophy	0.000	0.998	0.002
F31 Bipolar affective disorder	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.001
M24.17 Other articular cartilage disorders (Ankle and foot)	0.002	0.998	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.000	0.998	0.001
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.000	0.998	0.001
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.000	0.998	0.001
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.000	0.998	0.001
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.000	0.998	0.001
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.000	0.998	0.001
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.000	0.998	0.001
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.000	0.998	0.001
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.000	0.998	0.001
M94.19 Relapsing polychondritis (Site unspecified)	0.000	0.998	0.001
M94.18 Relapsing polychondritis (Other)	0.000	0.998	0.001
M94.17 Relapsing polychondritis (Ankle and foot)	0.000	0.998	0.001
M94.16 Relapsing polychondritis (Lower leg)	0.000	0.998	0.001
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.000	0.998	0.001
M94.14 Relapsing polychondritis (Hand)	0.000	0.998	0.001
M94.13 Relapsing polychondritis (Forearm)	0.000	0.998	0.001
M94.12 Relapsing polychondritis (Upper arm)	0.000	0.998	0.001
M94.11 Relapsing polychondritis (Shoulder region)	0.000	0.998	0.001
M94.10 Relapsing polychondritis (Multiple sites)	0.000	0.998	0.001
M94.39 Chondrolysis (Site unspecified)	0.000	0.998	0.001
M94.38 Chondrolysis (Other)	0.000	0.998	0.001
M94.37 Chondrolysis (Ankle and foot)	0.000	0.998	0.001
M94.36 Chondrolysis (Lower leg)	0.000	0.998	0.001
M94.35 Chondrolysis (Pelvic region and thigh)	0.000	0.998	0.001
M94.34 Chondrolysis (Hand)	0.000	0.998	0.001
M94.33 Chondrolysis (Forearm)	0.000	0.998	0.001
M94.32 Chondrolysis (Upper arm)	0.000	0.998	0.001
M94.31 Chondrolysis (Shoulder region)	0.000	0.998	0.001
M94.30 Chondrolysis (Multiple sites)	0.000	0.998	0.001
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.998	0.002
L66.8 Other cicatricial alopecia	0.000	0.998	0.001
W29.9 Unspecified place	0.000	0.998	0.002
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.998	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
M84.06 Malunion of fracture (Lower leg)	0.000	0.998	0.002
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.000	0.998	0.001
T42.0 Hydantoin derivatives	0.000	0.998	0.002
L72 Follicular cysts of skin and subcutaneous tissue	0.000	0.998	0.002
M94.29 Chondromalacia (Site unspecified)	0.000	0.998	0.001
M94.28 Chondromalacia (Other)	0.000	0.998	0.001
M94.27 Chondromalacia (Ankle and foot)	0.000	0.998	0.001
M94.25 Chondromalacia (Pelvic region and thigh)	0.000	0.998	0.001
M94.24 Chondromalacia (Hand)	0.000	0.998	0.001
M94.23 Chondromalacia (Forearm)	0.000	0.998	0.001
M94.22 Chondromalacia (Upper arm)	0.000	0.998	0.001
M94.21 Chondromalacia (Shoulder region)	0.000	0.998	0.001
M94.20 Chondromalacia (Multiple sites)	0.000	0.998	0.001
K52.8 Other specified non-infective gastro-enteritis and colitis	0.000	0.998	0.002
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.001	0.998	0.001
L75 Apocrine sweat disorders	0.000	0.998	0.001
L74 Eccrine sweat disorders	0.000	0.998	0.001
L67 Hair colour and hair shaft abnormalities	0.000	0.998	0.001
L64 Androgenic alopecia	0.000	0.998	0.001
L62 Nail disorders in diseases classified elsewhere	0.000	0.998	0.001
H21.9 Disorder of iris and ciliary body, unspecified	0.001	0.998	0.000
H21.4 Pupillary membranes	0.001	0.998	0.000
L63 Alopecia areata	0.000	0.998	0.001
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.002	0.998	0.000
J06.0 Acute laryngopharyngitis	0.000	0.998	0.001
C78.4 Secondary malignant neoplasm of small intestine	0.001	0.998	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.001	0.998	0.000
Z91.5 Personal history of self-harm	0.000	0.998	0.002
H20 Iridocyclitis	0.001	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.001	0.999	0.000
M84.04 Malunion of fracture (Hand)	0.000	0.999	0.001
H21.3 Cyst of iris, ciliary body and anterior chamber	0.001	0.999	0.000
H80.9 Otosclerosis, unspecified	0.000	0.999	0.001
C22.0 Liver cell carcinoma	0.001	0.999	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.999	0.001
J06.8 Other acute upper respiratory infections of multiple sites	0.000	0.999	0.001
H17 Corneal scars and opacities	0.001	0.999	0.000
L89 Decubitus ulcer	0.000	0.999	0.001
M94.26 Chondromalacia (Lower leg)	0.000	0.999	0.001
K70.0 Alcoholic fatty liver	0.000	0.999	0.001
L89.2 Stage III decubitus ulcer	0.000	0.999	0.001
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.999	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.999	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.999	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.999	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.999	0.001
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.999	0.001
D14.3 Bronchus and lung	0.001	0.999	0.000
L68 Hypertrichosis	0.000	0.999	0.001
M65.87 Other synovitis and tenosynovitis (Ankle and foot)	0.001	0.999	0.000
F31.8 Other bipolar affective disorders	0.001	0.999	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.999	0.001
L62.8 Nail disorders in other diseases classified elsewhere	0.000	0.999	0.001
L62.0 Clubbed nail pachydermoperiostosis	0.000	0.999	0.001
L64.9 Androgenic alopecia, unspecified	0.000	0.999	0.001
L64.8 Other androgenic alopecia	0.000	0.999	0.001
L64.0 Drug-induced androgenic alopecia	0.000	0.999	0.001
L67.9 Hair colour and hair shaft abnormality, unspecified	0.000	0.999	0.001
L67.8 Other hair colour and hair shaft abnormalities	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations